Not all sufferers with CLL involve therapy. In spite of all new innovations, the iwCLL still recommends watchful observation for clients with asymptomatic disorder.86 This suggestion is based on a minimum of two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). yang terbaru setiap https://atecap036uze5.blogtov.com/profile